Search
Feed aggregator
Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris
Amgen Wins FDA Approval for First Biosimilar to AstraZeneca’s Soliris 5/29/2024
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters 5/29/2024
Insmed Stock Surges After Brensocatib Aces Phase III Lung Disease Study
Insmed Stock Surges After Brensocatib Aces Phase III Lung Disease Study 5/29/2024
AstraZeneca’s Ambitious Target, Pharma Layoffs Continue and ASCO
AstraZeneca’s Ambitious Target, Pharma Layoffs Continue and ASCO 5/29/2024
Who Will the Next “Big Pharma” Players Be?
Who Will the Next “Big Pharma” Players Be? 5/29/2024
How Realistic is AstraZeneca’s $80B Revenue Target by 2030?
How Realistic is AstraZeneca’s $80B Revenue Target by 2030? 5/29/2024
J&J Scores Phase III Victory in Major Depressive Disorder
J&J Scores Phase III Victory in Major Depressive Disorder 5/29/2024
Biopharma IPOs From the First Half of 2024
Biopharma IPOs From the First Half of 2024 5/29/2024
Can AI Help Biopharma Companies Go Green?
Can AI Help Biopharma Companies Go Green? 5/29/2024
AstraZeneca Touts Early-Stage Results for Oral PCSK9 Inhibitor
AstraZeneca Touts Early-Stage Results for Oral PCSK9 Inhibitor 5/29/2024
J&J Inks $1.25B Deal to Buy Rights to Atopic Dermatitis Candidate from Numab
J&J Inks $1.25B Deal to Buy Rights to Atopic Dermatitis Candidate from Numab 5/28/2024
Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics
Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics 5/28/2024
AstraZeneca, Daiichi Sankyo ADC Misses Endpoint in Phase III NSCLC Study
AstraZeneca, Daiichi Sankyo ADC Misses Endpoint in Phase III NSCLC Study 5/28/2024
NS Pharma’s DMD Candidate Viltespo Fails Confirmatory Phase III Trial
NS Pharma’s DMD Candidate Viltespo Fails Confirmatory Phase III Trial 5/28/2024
Novo Nordisk’s Once-Weekly Insulin Loses FDA Adcomm Vote for Type 1 Diabetes
Novo Nordisk’s Once-Weekly Insulin Loses FDA Adcomm Vote for Type 1 Diabetes 5/28/2024
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins
Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins 5/28/2024
30 Years After Genetic Discovery, Huntington’s Patients Still Waiting
30 Years After Genetic Discovery, Huntington’s Patients Still Waiting 5/28/2024
Despite Progress, ADCs Still Stalled in Non-Small Cell Lung Cancer
Despite Progress, ADCs Still Stalled in Non-Small Cell Lung Cancer 5/28/2024
Precision Medicine and Novel Approaches on Cusp of Breaking Through in Psychiatry
Precision Medicine and Novel Approaches on Cusp of Breaking Through in Psychiatry 5/28/2024
Opinion: How to Make Today’s Clinical Research More Efficient
Opinion: How to Make Today’s Clinical Research More Efficient 5/28/2024
World Pharma News
- U.S. FDA grants full approval to Pfizer's BRAFTOVI combination regimen in first-line metastatic colorectal cancer
- New antibody-drug conjugate strategy to block HIV infection
- Rhododendron-derived drugs now made by bacteria
- Lung cancer drug offers a surprising new treatment against ovarian cancer
- Researchers identify promising Alzheimer's disease drug target